These aspects, which are seminal in cancer research, may provide novel insights on the role of PrPC as both a prognostic biomarker and a potential therapeutic target to force CSC to shift towards more differentiated and therapy-sensitive cancer cells. The gene discussed is PRNP; the disease is cancer.